These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14556927)

  • 1. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy.
    Daoud J; Toumi N; Bouaziz M; Ghorbel A; Jlidi R; Drira MM; Frikha M
    Eur J Cancer; 2003 Nov; 39(16):2349-54. PubMed ID: 14556927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases].
    Khanfir A; Frikha M; Ghorbel A; Karray H; Drira MM; Daoud J
    Cancer Radiother; 2006 Dec; 10(8):545-9. PubMed ID: 16807035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy.
    Zubizarreta PA; D'Antonio G; Raslawski E; Gallo G; Preciado MV; Casak SJ; Scopinaro M; Morales G; Sackmann-Muriel F
    Cancer; 2000 Aug; 89(3):690-5. PubMed ID: 10931470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].
    Frikha M; Toumi N; Ghorbel L; Ben Salah H; Khabir A; Karray H; Gargouri R; Boudawara T; Ghorbel A; Daoud J
    Cancer Radiother; 2010 Jun; 14(3):169-75. PubMed ID: 20347607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma.
    Chua DT; Sham JS; Wei WI; Ho WK; Au G; Choy D
    Head Neck; 2002 Apr; 24(4):350-60. PubMed ID: 11933177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
    Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
    J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy.
    Bachouchi M; Cvitkovic E; Azli N; Gasmi J; Cortes-Funes H; Boussen H; Rahal M; Kalifa C; Schwaab G; Eschwege F
    J Natl Cancer Inst; 1990 Apr; 82(7):616-20. PubMed ID: 1690306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
    Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
    Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
    Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
    J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.
    ;
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):463-9. PubMed ID: 8655368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
    Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
    Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
    Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis.
    Chua DT; Sham JS; Au GK; Choy D
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):334-43. PubMed ID: 12023137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie.
    Mertens R; Granzen B; Lassay L; Gademann G; Hess CF; Heimann G
    Cancer; 1997 Sep; 80(5):951-9. PubMed ID: 9307197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.